BioSpectra Revenue and Competitors
Estimated Revenue & Valuation
- BioSpectra's estimated annual revenue is currently $25.9M per year.
- BioSpectra's estimated revenue per employee is $201,000
- BioSpectra has 129 Employees.
- BioSpectra grew their employee count by 25% last year.
BioSpectra Competitors & Alternatives
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Valuation|
What Is BioSpectra?
BioSpectra is a FDA registered, cGMP compliant, contract manufacturer and commercial producer of biological buffers, pharmaceutical excipients and laboratory reagents. BioSpectra manufactures pH stabilizing biological buffers for the biopharmaceutical industry. These biological buffers offer low UV absorptivity, minimal reactivity, stable pH and high solubility in water for use in various biological applications. The excipients offered by BioSpectra’s Bulk BioPharm Manufacturing Division are produced in accordance with cGMP guidelines to provide the highest quality materials available to the biopharmaceutical industry. These excipients include Tromethamine, Tris Hydrochloride, Urea, Ammonium Sulfate, Guanidine Hydrochloride, MOPS, HEPES, MES and other related intermediates.keywords:N/A
Number of Employees
Employee Growth %
... Biological Industries, Cayman Chemical, SERVA Electrophoresis GmbH, Bio-Techne, BioSpectra, Corning, FUJIFILM Irvine Scientific, Dojindo Laboratories,...
In 2021, the biggest donors were Jodey Mutchler and Richard Mutchler, the president of pharmaceutical firm Biospectra, who gave $100,000.
|Company Name||Revenue||Number of Employees||Employee Growth||Total Funding|